Pharming Group to Announce Q3 2024 Financial Results Soon

Legal Turbulence for Aardvark Therapeutics There are rough seas ahead for Aardvark Therapeutics, folks. Investors in the biopharmaceutical firm (NASDAQ: AARD) are facing a securities fraud class action, catalyzed by potentially misleading statements regarding their flagship drug, ARD-101. The litigation clock ticks; October 13, 2026, is the deadline for unfortunate...

LaserAway's Latest Milestone: The 230th Clinic Over the years, I've seen companies skyrocket and nosedive faster than I can gulp down my morning coffee. LaserAway, though, seems to have crafted its own brand of magic. This crew just cut the ribbon on their 230th clinic right in Washington, DC. That's a might impressive feat for a company that started two decades ago out...

SuperX Makes Its Aussie Debut with a Bold AI Move Well, here comes a play not for the faint-hearted in the AI game. SuperX, hanging its hat up on the NASDAQ under the nifty ticker SUPX, has just scored big-time by pulling off a deal that's got eyebrows raising and minds whirling. An Aussie debut with a purchase order for 128 of those spiffy NVIDIA B300 AI servers? That's...

New Horizons in Healthcare: A Partnership with Purpose Who would've thought that a good night’s sleep could tie so tightly to heart health? Well, Philips Korea and HoneyNaps sure did, marking August 19, 2026, with a strategic marriage of their expertise. They've inked a memorandum of understanding (MOU) to dive deep into the mingling waters of sleep disorders and...

Investors and the Looming Deadline Dust off those investment papers if you're tangled up with Alibaba—NYSE: BABA. The clock's ticking as the chance to spearhead a class action suit hits its final stretch. The firm Hagens Berman Sobol Shapiro LLP is rallying investors who've seen their cash evaporate thanks to Alibaba’s murky dealings. You’ve got until October 5,...

Leifras Marks a Quarter-Century of Growth Leifras Co., Ltd. recently hit their 25th anniversary with the air of unapologetic ambition that only years of groundwork can justify. From humble beginnings in 2001, they've maneuvered their way to the forefront of Japan's youth sports scene. They're not one to rest on their laurels—no sir. Instead, they're leveraging their...

Freshness and Tradition Meet in a Kiwi In a world where food buzzwords like 'fresh' and 'natural' keep getting thrown around like last night's confetti, what's really grabbing the spotlight here is that slice of kiwi from Imathia, Greece. Thanks to this New York edible revelation, you won’t just be chomping on any ordinary fruit. Nope, these kiwis pack a punch with...

An Explosion of Art in the Baltic Sea Who knew a short ferry hop could take you into an art world like Helsinki's? The historic island of Vallisaari—once just stones and sea under Finland's bright summer sky—will bristle with creativity as Helsinki Biennial returns in 2027. It's a treat for the senses that you can almost smell on the salty breezes and vibrant cultural...

A Homebuilder with a Heart for Community Here's a story you don't see every day: a big name in housing more interested in hammering nails for a good cause than chasing profits. Clayton®, that's the name, and they're celebrating the fifth birthday of their gutsy initiative, Clayton Impact®. Since 2021, this program's empowered employees to volunteer significant chunks of...

Cogent's Legal Tangle: What's at Stake? Every seasoned investor’s tension point: Legal landscapes are beasts of their own. But when it involves a name like Cogent Communications Holdings (NASDAQ:CCOI), that's a beast you've got to reckon with. The Allegations Stir the Pot Here's the kicker. Robbins Geller Rudman & Dowd LLP hasn't just filed any ordinary...

SoCalGas to Provide Valuable Resources at World Ag Expo SoCalGas is set to engage with communities during the World Ag Expo, a premier event where customers from the San Joaquin Valley can access crucial information about safety, energy affordability, and reliability programs. Staff from SoCalGas will be present to address inquiries and offer resources to the public. The...

PTC Therapeutics and Novartis Announce Major Collaboration PTC Therapeutics, Inc. (NASDAQ: PTCT), known for its groundbreaking advances in pharmaceutical innovation, has partnered with Novartis Pharmaceuticals Corporation in an exciting global licensing agreement focused on the PTC518 program for Huntington's disease. This agreement comes with a significant financial...

Exciting Updates from Aker Horizons ASA Aker Horizons ASA is poised to release its financial results for the third quarter of 2024 on a forthcoming date. This announcement is eagerly awaited by investors and stakeholders alike, which demonstrates the company's commitment to transparency and progress in the green energy sector. Presentation Timing Details On the day of the...

Market Dynamics Under Pressure: Dollar Weakness and Market Sentiment Recent trends indicate that the US dollar is facing significant challenges, struggling to recover as various economic indicators stir responses across global markets. Last week, equity indices achieved a notable upswing, particularly driven by a robust 3.7% gain in the US 100 index. This positive...

Piper Sandler Elevates Tesla Price Target Investment bank Piper Sandler has raised its price target for Tesla Inc. (NASDAQ: TSLA) to $500. This update follows a recent visit where the firm engaged with officials from notable electric vehicle (EV) manufacturers such as Li Auto Inc. (NASDAQ: LI) and Stellantis NV (NYSE: STLA). The discussions highlighted important trends in...